Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Addict Sci Clin Pract. 2024 Jun 25;19(1):51. doi: 10.1186/s13722-024-00480-8.
ABSTRACT
BACKGROUND: Clinic-based interventions are needed to promote successful direct acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection in patients with substance use disorders (SUDs) among rural Veterans.
METHODS: We implemented a clinic-based intervention which used motivational interviewing (MI) techniques to promote medication adherence and treatment completion with 12 weeks of DAA treatment among rural Veterans with chronic HCV and SUDs. Patients received an MI session with a licensed psychologist at baseline and at each two-week follow-up visit during DAA treatment. Patients received $25 per study visit completed. Patients were to attend a laboratory visit 12 weeks after treatment completion to assess for sustained virologic response (SVR).
RESULTS: Of the 20 participants who enrolled, 75% (n = 15) completed the planned 12-week course of treatment. Average adherence by pill count was 92% (SD = 3%). Overall SVR was 95% (19/20).
CONCLUSIONS: We demonstrated that a clinic-based intervention which incorporated frequent follow up visits and MI techniques was feasible and acceptable to a sample of predominantly rural Veterans with chronic HCV and SUDs.
CLINICAL TRIAL REGISTRATION: Registered at ClinicalTrials.gov (NCT02823457) on July 1, 2016. https://clinicaltrials.gov .
PMID:38918869 | DOI:10.1186/s13722-024-00480-8
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database Hepatitis C Cascade of Care in a Multidisciplinary Substance Use Bridge Clinic Model in Tennessee Hepatitis C Cascade of Care in a Multidisciplinary Substance Use Bridge Clinic Model in Tennessee Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study Adherence and sustained virologic response among vulnerable people initiating an hepatitis C treatment at a nurse-led clinic: A non-experimental prospective cohort study based on clinical records Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia? Microelimination of Hepatitis C in patients with substance use and dual disorders - a Portuguese study Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial Contingency management for substance use disorders in the U.S. Veterans Health Administration: 2018-2022 PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs The role of psychiatric symptoms, sociodemographic factors, and baseline sleep variables on pediatric insomnia treatment outcomes in a clinically referred population Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders Sex, Adverse Childhood Experiences, and Substance Use Disorders in US Military Veterans: Results From the National Health and Resilience in Veterans Study Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol Psychological processes and alcohol reduction in patients with chronic hepatitis C: Results from the HepART trial Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort Barriers to accessing care among rural women veterans: A qualitative study with veterans, peer specialists, and primary care professionals Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease? Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway Home-based primary care providers' perspectives on the unique challenges of working with late life posttraumatic stress disorder within their population of Veterans Do veterans with risky substance use (RSU) use distinct pain treatment modalities? Treating Benzodiazepine Withdrawal in a Bridge Clinic Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration Factors Associated With Increased Substance Use Disorder Care in VA PTSD Specialty Outpatient Treatment Factors Associated With Increased Substance Use Disorder Care in VA PTSD Specialty Outpatient Treatment Clusters Based on Within-Treatment Symptom Trajectories as Predictors of Dropout in Treatment for Posttraumatic Stress Disorder and Substance Use Disorder Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes Confidence in providing methadone maintenance treatment of primary care providers in Vietnam Imaging neuroinflammation in individuals with substance use disorders Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up Nurses and Nursing Students With Substance Use Disorders Efficacy of assisted partner services for people who inject drugs in Kenya to identify partners living with HIV and hepatitis C virus infection: a prospective cohort study Experiences of schizophrenia patients with treatment buddy support during the COVID-19 pandemic Duloxetine and cognitive behavioral therapy with phone-based support for the treatment of chronic musculoskeletal pain: study protocol of the PRECICE randomized control trial Restore and Rebuild (R&R): a protocol for a phase 2, randomised control trial to compare R&R as a treatment for moral injury-related mental health difficulties in UK military veterans to treatment as usual Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process The Importance of Nurse-Patient Relationships in the Midst of Substance Misuse: Support for Rural Youth Well-Being Adherence Rates and Barriers to Second-Generation Antipsychotic Medication Use in Youth with Bipolar Spectrum Disorders Who Have Overweight/Obesity Observations of substance use treatment engagement during the period of community re-entry following residential treatment Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations Difficult-to-Engage Patients with Severe Mental Illness in Rural Community Settings: Results of the Greek Hybrid Assertive Community Treatment Model of Mental Healthcare Difficult-to-Engage Patients with Severe Mental Illness in Rural Community Settings: Results of the Greek Hybrid Assertive Community Treatment Model of Mental Healthcare Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances Predictive modeling of initiation and delayed mental health contact for depression A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone Examining the impact of substance use on hospital length of stay in schizophrenia spectrum disorder: a retrospective analysis Implementation of an "opt-out" tobacco treatment program in six hospitals in South Carolina Digital mental health interventions as stand-alone vs. augmented treatment as usual Co-occurring Chronic Pain and PTSD Among US Military Veterans: Prevalence, Correlates, and Functioning Emotions in search of words: Does alexithymia predict treatment outcome in chronic musculoskeletal pain? Effectiveness of internet-delivered cognitive behavioural therapy for anxiety and obsessive-compulsive disorders within routine clinical care in rural Sweden Association of Anxiety and Depressive Symptoms and Treatment Adherence Among Patients With Type 2 Diabetes Mellitus in Jazan, Saudi Arabia: A Cross-Sectional Study
Evidence Blueprint
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Supporting direct acting antiviral medication adherence and treatment completion in a sample of predominantly rural veterans with hepatitis C and substance use disorders Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders Antiviral Treatment and Response are Associated With Lower Risk of Dementia Among Hepatitis C Virus-Infected Patients Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital Substance Use after Completion of an Intensive Treatment Program with Concurrent Treatment for Posttraumatic Stress Disorder and Substance Use among Veterans: Examining the Role of PTSD Symptoms Late presentation for hepatitis C treatment: prevalence and risk factors in the Swiss Hepatitis C Cohort Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial A Quality Improvement Project: Implementation of the Centers for Disease Control and Prevention's Hepatitis C Virus Treatment Guidelines at an Addiction Treatment Center Hepatitis C Cascade of Care in a Multidisciplinary Substance Use Bridge Clinic Model in Tennessee Hepatitis C Cascade of Care in a Multidisciplinary Substance Use Bridge Clinic Model in Tennessee Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients Adherence and sustained virologic response among vulnerable people initiating an hepatitis C treatment at a nurse-led clinic: A non-experimental prospective cohort study based on clinical records Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder Screening and Follow-Up Care for Perinatal Mood and Anxiety Disorders at a Rural Obstetric Clinic Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia? Microelimination of Hepatitis C in patients with substance use and dual disorders - a Portuguese study Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study Mortality related to HCV and other chronic liver diseases in Veneto (Italy), 2008-2021: Changes in trends and age-period-cohort effects Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials Secure Messaging Intervention in Patients Starting New Antidepressant to Promote Adherence: Pilot Randomized Controlled Trial Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial The Impact of Cognitive Behavioral Therapy for Substance Use Disorders on Veterans' Interpersonal Difficulties Contingency management for substance use disorders in the U.S. Veterans Health Administration: 2018-2022 PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs Critical care for patients with substance use disorders The role of psychiatric symptoms, sociodemographic factors, and baseline sleep variables on pediatric insomnia treatment outcomes in a clinically referred population Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders Examining trauma, anxiety, and depression as predictors of dropout from residential treatment for substance use disorders Sex, Adverse Childhood Experiences, and Substance Use Disorders in US Military Veterans: Results From the National Health and Resilience in Veterans Study Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol Psychological processes and alcohol reduction in patients with chronic hepatitis C: Results from the HepART trial Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial 'We've got a present for you': Hepatitis C elimination, compromised healthcare subjects and treatment as a gift Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort Barriers to accessing care among rural women veterans: A qualitative study with veterans, peer specialists, and primary care professionals Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease? Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help? Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems Home-based primary care providers' perspectives on the unique challenges of working with late life posttraumatic stress disorder within their population of Veterans Do veterans with risky substance use (RSU) use distinct pain treatment modalities? Treating Benzodiazepine Withdrawal in a Bridge Clinic Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges Pilot randomized controlled trial of a brief strategy to prevent suicide after discharge from residential addiction treatment Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design protocol Perspectives of homeless veterans living with substance use disorders (SUD) and mental illness